These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 29393479

  • 1. Synergistic effect of metformin and medroxyprogesterone 17‑acetate on the development of endometrial cancer.
    Mu N, Dong M, Li L, Xia M, Qv L, Wang Y, Dong C, Chen Y, Zuo Y, Hou J, Xue F.
    Oncol Rep; 2018 Apr; 39(4):2015-2021. PubMed ID: 29393479
    [Abstract] [Full Text] [Related]

  • 2. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
    Niu YJ, Shi HR, Xie Y.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
    [Abstract] [Full Text] [Related]

  • 3. 5-aza-2'-deoxycytidine improves the sensitivity of endometrial cancer cells to progesterone therapy.
    Hu Q, Yu L, Chen R, Wang YL, Ji L, Zhang Y, Xie Y, Liao QP.
    Int J Gynecol Cancer; 2012 Jul; 22(6):951-9. PubMed ID: 22683940
    [Abstract] [Full Text] [Related]

  • 4. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y, Wang YL, Yu L, Hu Q, Ji L, Zhang Y, Liao QP.
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [Abstract] [Full Text] [Related]

  • 5. MET Inhibits the Proliferation of EC Cells by Increasing MPA Sensitivity.
    Sun F, Zhou J, Hao Y, Kuang L, Zhang B.
    Altern Ther Health Med; 2023 Jul; 29(5):334-341. PubMed ID: 37171945
    [Abstract] [Full Text] [Related]

  • 6. Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells.
    Cao W, Gao W, Zheng P, Sun X, Wang L.
    BMC Med Genomics; 2019 Nov 12; 12(1):163. PubMed ID: 31718641
    [Abstract] [Full Text] [Related]

  • 7. [Study of mechanism of medroxyprogesterone 17-acetate on the cancer stem cell-like properties of human endometrial cancer].
    Liu BJ, Li XP, Zhao LJ, Wang JL, Wei LH.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct 12; 48(10):772-7. PubMed ID: 24406136
    [Abstract] [Full Text] [Related]

  • 8. Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancer.
    Gu W, Mitsuhashi A, Kobayashi T, Shozu M.
    BMC Cancer; 2022 Jul 11; 22(1):753. PubMed ID: 35820883
    [Abstract] [Full Text] [Related]

  • 9. Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo.
    Cao C, Zhou JY, Xie SW, Guo XJ, Li GT, Gong YJ, Yang WJ, Li Z, Zhong RH, Shao HH, Zhu Y.
    Int J Mol Sci; 2019 Jul 05; 20(13):. PubMed ID: 31284427
    [Abstract] [Full Text] [Related]

  • 10. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
    Xu Y, Tong J, Ai Z, Wang J, Teng Y.
    J Obstet Gynaecol Res; 2012 Dec 05; 38(12):1358-66. PubMed ID: 22612393
    [Abstract] [Full Text] [Related]

  • 11. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z, Qi S, Zhao X, Li M, Ding S, Lu J, Zhang H.
    Oncotarget; 2016 Apr 19; 7(16):21315-31. PubMed ID: 26824324
    [Abstract] [Full Text] [Related]

  • 12. Centchroman induces redox-dependent apoptosis and cell-cycle arrest in human endometrial cancer cells.
    Shyam H, Singh N, Kaushik S, Sharma R, Balapure AK.
    Apoptosis; 2017 Apr 19; 22(4):570-584. PubMed ID: 28176146
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S, Chen X, Lu X, Yu Y, Feng Y.
    Gynecol Oncol; 2007 Apr 19; 105(1):45-54. PubMed ID: 17240435
    [Abstract] [Full Text] [Related]

  • 14. The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.
    Hanifi-Moghaddam P, Sijmons B, Ott MC, van Ijcken WF, Nowzari D, Kuhne EC, van der Spek P, Kloosterboer HJ, Burger CW, Blok LJ.
    J Mol Endocrinol; 2006 Dec 19; 37(3):405-13. PubMed ID: 17170081
    [Abstract] [Full Text] [Related]

  • 15. Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib.
    Faigenbaum R, Haklai R, Ben-Baruch G, Kloog Y.
    Oncotarget; 2013 Feb 19; 4(2):316-28. PubMed ID: 23530112
    [Abstract] [Full Text] [Related]

  • 16. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S, Giordano C, Rizza P, Gu G, Barone I, Bonofiglio D, Giordano F, Malivindi R, Gaccione D, Lanzino M, De Amicis F, Andò S.
    J Cell Physiol; 2009 Mar 19; 218(3):490-500. PubMed ID: 18988190
    [Abstract] [Full Text] [Related]

  • 17. Antitumor Effect of Apcin on Endometrial Carcinoma via p21-Mediated Cell Cycle Arrest and Apoptosis.
    Ni K, Li ZL, Hu ZY, Hong L.
    Curr Med Sci; 2024 Jun 19; 44(3):623-632. PubMed ID: 38853192
    [Abstract] [Full Text] [Related]

  • 18. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP, Pezzuto JM.
    Cancer Res; 2001 Aug 15; 61(16):6137-44. PubMed ID: 11507064
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway.
    Li LH, Zhang PR, Cai PY, Li ZC.
    Biomed Pharmacother; 2016 Aug 15; 82():161-6. PubMed ID: 27470351
    [Abstract] [Full Text] [Related]

  • 20. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
    He Z, Xu H, Meng Y, Kuang Y.
    Biomed Pharmacother; 2017 Apr 15; 88():902-910. PubMed ID: 28178620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.